Jeisys Medical Inc
KOSDAQ:287410
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Banaras Beads Ltd
NSE:BANARBEADS
|
IN |
|
I
|
Irm Energy Ltd
NSE:IRMENERGY
|
IN |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (25.2), the stock would be worth ₩12 889.87 (0% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 25.2 | ₩12 900 |
0%
|
| 3-Year Average | 25.2 | ₩12 889.87 |
0%
|
| 5-Year Average | 24.2 | ₩12 365.42 |
-4%
|
| Industry Average | 14.9 | ₩7 604.39 |
-41%
|
| Country Average | 12.5 | ₩6 418.36 |
-50%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
₩961.9B
|
/ |
Jul 2024
₩38.2B
|
= |
|
|
₩961.9B
|
/ |
Dec 2024
₩54.1B
|
= |
|
|
₩961.9B
|
/ |
Dec 2025
₩68.9B
|
= |
|
|
₩961.9B
|
/ |
Dec 2026
₩82.8B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
974B KRW | 25.2 | 34.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
161B USD | 19.2 | 25.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.3B USD | 52.2 | 56.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 23.9 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.2B USD | 18.5 | 22.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
88.3B USD | 24.4 | 30.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.9B EUR | 15.7 | 19.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 25.7 | 43.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 33.5 | 42.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 17 | 25.4 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.9B USD | 13.8 | 15.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.8 |
| Median | 12.5 |
| 70th Percentile | 23.2 |
| Max | 13 874.5 |
Other Multiples
Jeisys Medical Inc
Glance View
Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
